Your browser doesn't support javascript.
loading
Vitiligo as durvalumab's immune-related adverse event in lung cancer / Vitíligo como evento adverso inmunomediado secundario a durvalumab en cáncer de pulmón
Rogado, Jacobo; Buendía-Castaño, Diego; Alonso-García, Soledad R.
Affiliation
  • Rogado, Jacobo; Hospital Universitario Infanta Leonor. Madrid. Spain
  • Buendía-Castaño, Diego; Hospital Universitario Infanta Leonor. Madrid. Spain
  • Alonso-García, Soledad R; Hospital Universitario Infanta Leonor. Madrid. Spain
Med. clín (Ed. impr.) ; 158(7): 341-342, abril 2022. ilus
Article in Spanish | IBECS | ID: ibc-204506
Responsible library: ES1.1
Localization: BNCS
Subject(s)
Search on Google
Add to My VHL
Print
XML

Collection: National databases / Spain Database: IBECS Main subject: Vitiligo / Lung Neoplasms / Antibodies, Monoclonal Limits: Humans Language: Spanish Journal: Med. clín (Ed. impr.) Year: 2022 Document type: Article Institution/Affiliation country: Hospital Universitario Infanta Leonor/Spain
Search on Google
Add to My VHL
Print
XML

Collection: National databases / Spain Database: IBECS Main subject: Vitiligo / Lung Neoplasms / Antibodies, Monoclonal Limits: Humans Language: Spanish Journal: Med. clín (Ed. impr.) Year: 2022 Document type: Article Institution/Affiliation country: Hospital Universitario Infanta Leonor/Spain